Yang Luo, Chen Lin, Lu Chun-yan, Zheng Xun, Li Zhi-hui, Zhou Li. Radiofrequency ablation plus desomumab in the treatment of hemodialysis patients with triple hyperparathyroidism and osteoporosis： one case report[J]. Journal of Clinical Nephrology, 2022, 22(3): 259-262. DOI: 10.3969/j.issn.1671-2390.2022.03.015
|
Citation:
|
Yang Luo, Chen Lin, Lu Chun-yan, Zheng Xun, Li Zhi-hui, Zhou Li. Radiofrequency ablation plus desomumab in the treatment of hemodialysis patients with triple hyperparathyroidism and osteoporosis： one case report[J]. Journal of Clinical Nephrology, 2022, 22(3): 259-262. DOI: 10.3969/j.issn.1671-2390.2022.03.015
|
Yang Luo, Chen Lin, Lu Chun-yan, Zheng Xun, Li Zhi-hui, Zhou Li. Radiofrequency ablation plus desomumab in the treatment of hemodialysis patients with triple hyperparathyroidism and osteoporosis： one case report[J]. Journal of Clinical Nephrology, 2022, 22(3): 259-262. DOI: 10.3969/j.issn.1671-2390.2022.03.015
|
Citation:
|
Yang Luo, Chen Lin, Lu Chun-yan, Zheng Xun, Li Zhi-hui, Zhou Li. Radiofrequency ablation plus desomumab in the treatment of hemodialysis patients with triple hyperparathyroidism and osteoporosis： one case report[J]. Journal of Clinical Nephrology, 2022, 22(3): 259-262. DOI: 10.3969/j.issn.1671-2390.2022.03.015
|
.png)
DownLoad: